Cargando…
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder
The most frequent genetic alteration in transitional cell carcinoma of the urinary bladder (TCC) is loss of chromosome 9 which targets CDKN2A on 9p. The targets on 9q are not confirmed. Here, 81 advanced TCC specimens were investigated for loss of heterozygosity (LOH) and homozygous deletions (HD) o...
Autores principales: | Kimura, F, Florl, A R, Seifert, H-H, Louhelainen, J, Maas, S, Knowles, M A, Schulz, W A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364013/ https://www.ncbi.nlm.nih.gov/pubmed/11747331 http://dx.doi.org/10.1054/bjoc.2001.2154 |
Ejemplares similares
-
Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999) -
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
por: Milella, M, et al.
Publicado: (1999) -
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
por: Bartlett, J. M., et al.
Publicado: (1998) -
Somatic mutation of PTEN in bladder carcinoma
por: Aveyard, J S, et al.
Publicado: (1999) -
G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder
por: Niehans, G A, et al.
Publicado: (1999)